NEW YORK, Jan 10 – Qiagen Genomics said Wednesday that it has entered into three new licensing agreements involving its Masscode technology for high-throughput SNP genotyping.

The agreements, announced separately, involve Agilent Technologies, Japan’s Daiichi Pharmaceutical subsidiary of Daiichi Pure Chemicals (DPC), and the University of Washington School of Pharmacy.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.